Medtech

Medtech firm Murata Vios to double headcount in next five years in India

Specialising in medical-grade IoT sensors and remote monitoring services...

Scientists in Guwahati develop new device for wearable sensors and point-of-care testing

The response of the fabricated device was investigated with real samples...

First-time National Level Expo on Medical Devices sector taking place in Gujarat

Department and Industry Associations to organise 3 days National Level Expo in Gandhi Nagar, Gujarat...

MTaI invites diplomats from various countries to discuss opportunities for global players in India

In the day-long event, MTaI will hold various discussions with Diplomats and Industry Stakeholders for investment possibilities in the Indian medtech space...

Omron Healthcare enters at-home heart monitoring & management segment

Collaborates with Tricog to enable remote patient management ...

Manipal Hospitals enhances use of high-end minimally invasive procedures

Manipal Hospitals and Queen Elizabeth University Hospital – Interventional Radiology departments ink partnership...

How is the ‘Make in India’ MedTech transformation coming along?

The government has taken several cautious steps to fuel this promising sector. Strategic decisions such as foreign direct investments (FDI) promoting medical device parks are aimed to drive business. Let us look at how the industry has come along with this ‘Make in India’ initiative. ...

Koning Corporation Unveils Revolutionary AI-Enhanced Software to Boost Breast CT Image Quality

Koning Corporation, a global leader in breast computed tomography (CT) technology, is thrilled to announce the launch of its breakthrough Artificial Intelligence (AI) software, designed to enhance image quality significantly. The upgrade to their software system is set to provide unparalleled clarity in breast imaging, promising a game-changing impact on the early detection and treatment of breast cancer....

Roche Gets FDA Clearance for Additional Alzheimer's CSF Assays, Enhancing Diagnosis and Treatment Decisions

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its Elecsys® beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys® Total-Tau CSF assays (tTau) have received U.S. Food and Drug Administration (FDA) 510(k) clearance. The Elecsys AD CSF Abeta42 and tTau assays (used as a tTau/Abeta42 ratio) measure two biomarkers of Alzheimer's pathology, beta-amyloid and tau proteins, in adults ages 55 and older being evaluated for the disease....

Eko Health Launches CORE 500™ Digital Stethoscope with Heart Disease Detection AI and Advanced Features

Next-generation FDA-cleared medical device brings non-invasive heart and lung disease detection to healthcare professionals at the point of care ...